Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India Diagnostic concordance was observed in 296 cases ...

A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, "Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma." Pazopanib, a multi-kinase ...

International variation in overall survival linked to differences in childhood tumor stage distribution for some cancer types and regions.

Researchers from Kyushu University, Japan have developed a novel deep-learning model which can accurately estimate viable tumor cell density from pathological images of osteosarcoma patients, and ...

The largest studies of chemotherapy for bone sarcomas are in the pediatric population. Although increasing age is often found to be an adverse prognostic factor in these clinical trials, few studies ...